SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

First Patient Dosed in Phase 1 Trial of BT-001 for Rectal Cancer

Transgene and BioInvent report the first patient has been dosed in the Phase 1 trial evaluating BT-001 in patients with rectal cancer.

Story updates

07:01:48 AM UTC
SquawkNews
Transgene and University of Copenhagen are collaborating on the investigator-sponsored OV-PRIME-R tr

Related stories